Secukinumab (AIN457) is a high-affinity monoclonal antibody against interleukin (IL-17A). Secukinumab (AIN457) is the first-in-class anti-IL-17 agent to be used in studies of plaque psoriasis, ankylosing spondylitis, and psoriatic arthritis.
Molecular Weight:
147941.89
Purity:
>99%
CAS Number:
[875356-43-7]
Formula:
C6584H10134N1754O2042S44
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted